Abstract
Introduction
Novel vaccine administration technologies have the potential to improve
vaccine developers' commercial competitiveness and to increase vaccination
safety and convenience. This report assesses key strategies, technologies and
products for novel dermal and mucosal vaccine administration. It also provides
an overview of opportunities and challenges for the sector and a future
outlook.
Scope of this research
- In-depth analysis of key dermal and mucosal vaccine administration
technologies
- Thorough assessment of the potential for selected vaccine administration
technologies
- Review of industry and academic stakeholder opinions involved in the
vaccine administration sector
- In-depth discussion of key opportunities and risks for novel vaccine
administration technologies
Research and analysis highlights
Needle-free vaccine delivery into and through the skin is an important focus
of vaccine research, with key technologies including intradermal patches,
microneedles and needle-free liquid, solid and powder injectors. Recognizing
the skin as an important immunologic organ, researchers mainly hope for an
improved immune response using this approach.
The largest potential for success of mucosal vaccine delivery lies in oral and
intranasal administration, while pulmonary vaccination appears less promising
due concerns regarding safety and reliable dosing. Careful selection of
suitable indications for mucosal delivery routes will be key to success in
this challenging sector.
Antigen stability, safety and efficacy are the key hurdles for novel vaccine
administration technologies. In times of restricted healthcare budgets,
pricing and manufacturing costs of novel vaccine administration systems need
to be kept to a minimum. Only the careful selection of suitable indications
will offer a route to commercial success.
Key reasons to purchase this research
- Review profiles of key marketed and development-stage, dermal and mucosal
vaccine administration technologies and assess their future potential
- Gain insight into the current state of vaccine administration technologies
and their future opportunities and challenges
- Benefit from opinions of key industry and academic stakeholders in the
vaccine administration field
| 
View Cart
